Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Naloxone in Reducing Postictal Central Respiratory Dysfunction in Patients With Epilepsy

NCT02332447 is registered in ClinicalTrials.gov with Hospices Civils de Lyon as lead sponsor.

NCT NCT02332447
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02332447 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Naloxone in Reducing Postictal Central Respiratory Dysfunction in Patients With Epilepsy
Lead sponsor
Hospices Civils de Lyon
Phase
Phase 3
Overall status
Completed
Start date
June 26, 2015
Completion date
July 30, 2020
Enrollment
485 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

epilepsy